North America Dry Eye Syndrome Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Jul 2019
  • North America
  • 350 Pages
  • No of Tables: 102
  • No of Figures: 29

North America Dry Eye Syndrome Market By Product Type (Tear stimulators, Artificial tears, Secretagogue, Others), Dosage Type (Liquid, Semi-solid, Others), Drug Class (Lubricating Agents, Cholinergics, Anti-Inflammatory, Anti-Infectives, Anti-Allergics, Others), Dose( Unit dose, Multi-dose), Medication Type( Prescription (Rx) Drugs, Over The Counter (OTC) Drugs), Container Type (Unit-Dose Vials, Bottles, Tubes), Packaging Type( Plastic, Aluminium, Glass), Type (Brands, Generics), End Users (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2026

Dry eye is a multifactorial disease of the tears and ocular surface that causes symptoms of disquiet visual disturbance and tears film variability with possible damage to the ocular surface. It is escorted increase in tear film osmolality and ocular surface inflammation which may result in substantial damage of eye. The symptoms of dry eye syndrome includes eye redness, blurred vision and eye fatigue, Watery eyes, which are the body's response to the irritation of dry eyes such as a stinging burning and scratchy sensation in eyes.

North America dry eye syndrome market is projected to register a healthy CAGR in the forecast period 2019 to 2026.

Segmentation: North America Dry Eye Syndrome Market

North America  dry eye syndrome market is segmented into ten notable segments on the basis of product type, dosage type, drug class, dose, medication type, container type, packaging type, type, end user and distribution channel.

·         On the basis of product type, the market is segmented into tear stimulators, artificial tears, secretagogue and others

·         On the basis of dosage type, the market is segmented into liquid, semi solid and others

·         On the basis of drug class, the market is segmented into anti-inflammatory, lubricating agents, anti-infectives, anti-allergics, cholinergics and others

·         On the basis of dose, the market is segmented into multi dose and unit dose

·         On the basis of medication type, the market is segmented into prescription (RX) drugs, and over the counter (OTC) drugs

·         On the basis of container type, the market is segmented into unit dose vials, bottles, and tubes

·         On the basis of packaging type, the market is segmented into plastic, glass, and aluminium

·         On the basis of type, the market is segmented into generics and brands

·         On the basis of end user, the market is segmented into home healthcare, hospitals, clinics, and others

·         On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others

Competitive Analysis: North America Dry Eye Syndrome Market

Some of the major players operating in the North America  dry eye syndrome market are Allergan, Bausch & Lomb Incorporated, Novartis Ag, Johnson & Johnson Services, Inc., Prestige Consumer Healthcare, Inc., Akorn, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Novaliq Gmbh, Santen Pharmaceutical Co., Ltd., Cardinal Health, Alembic Pharmaceuticals Limited., Cipla Inc., Perrigo Company Plc, Senju Pharmaceutical Co. Ltd., Horus Pharma, Rohto Pharmaceutical Co., Ltd., Visufarma, Hubrx and others.

Recent Developments

·         In May 2019, Akorn, Inc. (U.S.) was presented at the 2019 RBC Capital Markets Healthcare Conference which was held on 22nd May in the U.S. This strategy will help the company to enhance their customer base

·         In May 2019, Johnson & Johnson (U.S.) Vision showcase their New Data and Innovations in Eye Care at the 2019 British Contact Lens Association Conference (BCLA) which was held in U.K. from 30th May and 1st June. This would help the company to focus on driving the transformational innovation for improving the vision performance and the comfort for patients across the world

·         In June 2018, Bausch & Lomb (U.S.) announced the launch of Soothe Xtra Protection (XP) Preservative Free lubricant eye drops to meet the rising demand of the dry eye symptoms relief without the usage of the preservatives. This will help the company to expand its product portfolio in the market

Research Methodology : North America Dry Eye Syndrome Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Bakers and Food Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers.


SKU-

TABLE 1 AGEING WORLD POPULATION

TABLE 2 NORTH AMERICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 3 NORTH AMERICA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 4 NORTH AMERICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 5 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 6 NORTH AMERICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 7 NORTH AMERICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 8 NORTH AMERICA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 9 NORTH AMERICA DIGITAL IN DRY EYE SYNDROME MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)

TABLE 10 NORTH AMERICA OTHERS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 11 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 12 NORTH AMERICA ANTI-INFLAMMATORY IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 NORTH AMERICA LUBRICATING AGENT IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 NORTH AMERICA ANTI-INFECTIVE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 NORTH AMERICA ANTI-ALLERGIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 NORTH AMERICA CHOLINERGIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 NORTH AMERICA OTHERS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 19 NORTH AMERICA MULTI DOSE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 NORTH AMERICA UNIT DOSE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 NORTH AMERICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 22 NORTH AMERICA PRESCRIPTION (RX) DRUGS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 NORTH AMERICA OVER THE COUNTER (OTC) DRUGS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 NORTH AMERICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 25 NORTH AMERICA UNIT DOSE VIALS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 NORTH AMERICA BOTTLES IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 NORTH AMERICA TUBES IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 NORTH AMERICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 29 NORTH AMERICA PLASTIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 NORTH AMERICA GLASS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 NORTH AMERICA ALUMINUM IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 NORTH AMERICA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 33 NORTH AMERICA GENERICS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 34 NORTH AMERICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 35 NORTH AMERICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 36 NORTH AMERICA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 37 NORTH AMERICA HOME HEALTHCARE IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 38 NORTH AMERICA HOSPITALS IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 39 NORTH AMERICA CLINICS IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 40 NORTH AMERICA OTHERS IN DRY EYE SYNDROME MARKET, BY END USER, 2016-2026 (USD MILLION)

TABLE 41 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 42 NORTH AMERICA HOSPITAL PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 43 NORTH AMERICA RETAIL PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 44 NORTH AMERICA ONLINE PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 45 NORTH AMERICA OTHERS IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2016-2026 (USD MILLION)

TABLE 46 NORTH AMERICA DRY EYE SYNDROME MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 47 NORTH AMERICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 48 NORTH AMERICA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 49 NORTH AMERICA TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 50 NORTH AMERICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 51 NORTH AMERICA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 52 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 53 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 54 NORTH AMERICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 55 NORTH AMERICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 56 NORTH AMERICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 57 NORTH AMERICA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 58 NORTH AMERICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 59 NORTH AMERICA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 60 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 61 U.S. DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 62 U.S. TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 63 U.S. TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 64 U.S. LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 65 U.S. SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 66 U.S. DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 67 U.S. DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 68 U.S. DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 69 U.S. DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 70 U.S. DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 71 U.S. DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 72 U.S. BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 73 U.S. DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 74 U.S. DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 75 CANADA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 76 CANADA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 77 CANADA TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 78 CANADA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 79 CANADA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 80 CANADA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 81 CANADA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 82 CANADA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 83 CANADA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 84 CANADA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 85 CANADA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 86 CANADA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 87 CANADA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 88 CANADA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 89 MEXICO DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 90 MEXICO TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 91 MEXICO TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 92 MEXICO LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 93 MEXICO SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 94 MEXICO DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 95 MEXICO DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 96 MEXICO DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 97 MEXICO DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 98 MEXICO DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 99 MEXICO DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 100 MEXICO BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 101 MEXICO DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 102 MEXICO DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE